Sjogrens Syndrome Market by Drug (Pilocarpine, Cyclosporine, NSAIDS, Hydroxychlroquine) By Type (Primary Sjogrens Syndrome, Secondary Sjogrens Syndrome) By End-User (Hospitals, Clinics, Pharmacies, Online Pharmacies) By Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Sjogrens Syndrome Market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on gives historical, current, and future market sizes (US$ Mn) on the basis of drug class, type, distribution channel and region. This report studies global variable air volume (VAV) systems market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged. Sjogrens syndrome is an immune disorder which is indicated by two common symptoms dry mouth and dry eyes. Sometimes sjogrens syndromes are associated with other immune disorders like rheumatoid arthritis and lupus. In this condition mucous membrane of mouth and eyes get affected, which results in decreased secretion of tears and saliva. Sjogrens disease can occur at any age, it is more common in women. in October 2015, Allergan introduced synthetic tears REFRESH OPTIVE gel drops to relieve dry eye symptoms. In November 2013, Nicox SA introduced advanced diagnostic panel for detection of sjogrens syndrome in early stages in U.S.

Sjogrens Syndrome Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Sjogrens Syndrome Market Dynamics

Growing incidence of sjogrens syndrome coupled with rising awareness the sjogrens syndrome are expected to drive the growth of sjogrens syndrome market. Furthermore, increase in patient pool with rheumatoid arthritis and lupus, environmental pollution, growing demand for the advanced treatments and therapies are expected to boost the growth of the sjogrens syndrome market. However, lack of awareness is a major drawback sjogrens syndrome market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Sjogrens Syndrome Market Segmentation

  • Pilocarpine
  • Cyclosporine
  • Hydroxychloroquine
  • Primary Sjogrens Syndrome
  • Secondary Sjogrens Syndrome
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online pharmacies
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and africa

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • Allergan Inc. (Ireland)
  • Auven Therapeutics (U.S.)
  • Novartis AG (Switzerland)
  • Santen Pharmaceutical Co. Ltd. (Japan)
  • Otsuka Pharmaceutical Co., Ltd. (Japan)
  • Argentis Pharmaceuticals, LLC. (UK)
  • Nicox S.A. (France)